FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2222669102> ?p ?o ?g. }

• W2222669102 endingPage "e0131565" @default.
• W2222669102 startingPage "e0131565" @default.
• W2222669102 abstract "A multi-centre, non-comparative study examining the efficacy and safety of Subgam, a normal immunoglobulin (IgG) given weekly as a rapid subcutaneous infusion to patients with primary immune deficiency (PID), is reported. Also included is a summary of adverse drug reactions associated with the use of marketed Subgam in the UK.50 patients with stable PID on IgG therapy were enrolled: Stage 1 included three infusions with prior IgG product followed by 6 months with Subgam, Stage 2 involved long-term Subgam therapy up to 4 years.Stage 1, 85% of the subjects aged >12 years and 93% of the subjects aged <12 years achieved IgG levels ≥6 and ≥4 g/L, respectively at all observations. There were 3.62 infections/patient/year during Subgam treatment. The most common product-related events were infusion site reactions (50% of patients). Recent post-hoc pharmacokinetics analysis of the post-infusion serum total IgG concentration indicated that the mean dose-normalised incremental IgG AUCτ following intravenous dosing (120.5 g.day/L) was 1.64-fold that of the dose-normalised mean incremental IgG AUCτ following subcutaneous dosing (73.6 g.day/L), corresponding to an estimated IgG bioavailability for subcutaneous dosing of 61%. Only 34 post-licensing adverse reactions have been received in 30 patients over a period of 10 years; fourteen were classed as serious as defined by the ICH guidelines on good clinical practice. The most common post-licensing adverse reaction was infusion site reaction (7 reports). There were 7 reports of flu-like symptoms (pyrexia/shivering/rigors/feeling hot or cold), 2 other reports of combined flu-like symptoms and infusion site reactions, 5 reports of generalised skin reactions, and 3 reports of combined infusion site and skin reactions. There were also reports of anaphylaxis (2 reports) and 8 other adverse events (including headache). In conclusion, Subgam is effective and well tolerated in the treatment of PID.ClinicalTrials.gov NCT02247141." @default.
• W2222669102 created "2016-06-24" @default.
• W2222669102 creator A5038575762 @default.
• W2222669102 creator A5056108327 @default.
• W2222669102 creator A5059293895 @default.
• W2222669102 creator A5063877045 @default.
• W2222669102 date "2015-07-29" @default.
• W2222669102 modified "2023-09-23" @default.
• W2222669102 title "Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov - NCT02247141)" @default.
• W2222669102 cites W124404536 @default.
• W2222669102 cites W1487079135 @default.
• W2222669102 cites W1899711695 @default.
• W2222669102 cites W1990890427 @default.
• W2222669102 cites W1996732435 @default.
• W2222669102 cites W2023927367 @default.
• W2222669102 cites W2028012402 @default.
• W2222669102 cites W2037581442 @default.
• W2222669102 cites W2046752196 @default.
• W2222669102 cites W2058522501 @default.
• W2222669102 cites W2077155461 @default.
• W2222669102 cites W2088701885 @default.
• W2222669102 cites W2090117112 @default.
• W2222669102 cites W2144131091 @default.
• W2222669102 cites W2330505390 @default.
• W2222669102 cites W2409374026 @default.
• W2222669102 cites W265320334 @default.
• W2222669102 cites W4290751260 @default.
• W2222669102 doi "https://doi.org/10.1371/journal.pone.0131565" @default.
• W2222669102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4519338" @default.
• W2222669102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26222441" @default.
• W2222669102 hasPublicationYear "2015" @default.
• W2222669102 type Work @default.
• W2222669102 sameAs 2222669102 @default.
• W2222669102 citedByCount "2" @default.
• W2222669102 countsByYear W22226691022015 @default.
• W2222669102 countsByYear W22226691022018 @default.
• W2222669102 crossrefType "journal-article" @default.
• W2222669102 hasAuthorship W2222669102A5038575762 @default.
• W2222669102 hasAuthorship W2222669102A5056108327 @default.
• W2222669102 hasAuthorship W2222669102A5059293895 @default.
• W2222669102 hasAuthorship W2222669102A5063877045 @default.
• W2222669102 hasBestOaLocation W22226691021 @default.
• W2222669102 hasConcept C112705442 @default.
• W2222669102 hasConcept C126322002 @default.
• W2222669102 hasConcept C159654299 @default.
• W2222669102 hasConcept C197934379 @default.
• W2222669102 hasConcept C203014093 @default.
• W2222669102 hasConcept C2776433325 @default.
• W2222669102 hasConcept C2777288759 @default.
• W2222669102 hasConcept C2780898057 @default.
• W2222669102 hasConcept C71924100 @default.
• W2222669102 hasConcept C90924648 @default.
• W2222669102 hasConceptScore W2222669102C112705442 @default.
• W2222669102 hasConceptScore W2222669102C126322002 @default.
• W2222669102 hasConceptScore W2222669102C159654299 @default.
• W2222669102 hasConceptScore W2222669102C197934379 @default.
• W2222669102 hasConceptScore W2222669102C203014093 @default.
• W2222669102 hasConceptScore W2222669102C2776433325 @default.
• W2222669102 hasConceptScore W2222669102C2777288759 @default.
• W2222669102 hasConceptScore W2222669102C2780898057 @default.
• W2222669102 hasConceptScore W2222669102C71924100 @default.
• W2222669102 hasConceptScore W2222669102C90924648 @default.
• W2222669102 hasIssue "7" @default.
• W2222669102 hasLocation W22226691021 @default.
• W2222669102 hasLocation W22226691022 @default.
• W2222669102 hasLocation W22226691023 @default.
• W2222669102 hasLocation W22226691024 @default.
• W2222669102 hasOpenAccess W2222669102 @default.
• W2222669102 hasPrimaryLocation W22226691021 @default.
• W2222669102 hasRelatedWork W1574394940 @default.
• W2222669102 hasRelatedWork W2029824831 @default.
• W2222669102 hasRelatedWork W2051764329 @default.
• W2222669102 hasRelatedWork W2152911432 @default.
• W2222669102 hasRelatedWork W2222669102 @default.
• W2222669102 hasRelatedWork W2800682907 @default.
• W2222669102 hasRelatedWork W3040573319 @default.
• W2222669102 hasRelatedWork W3197824728 @default.
• W2222669102 hasRelatedWork W3207313530 @default.
• W2222669102 hasRelatedWork W1962564742 @default.
• W2222669102 hasVolume "10" @default.
• W2222669102 isParatext "false" @default.
• W2222669102 isRetracted "false" @default.
• W2222669102 magId "2222669102" @default.
• W2222669102 workType "article" @default.